Clinical trials · New Jersey
Chronic Limb-Threatening Ischemia clinical trials in New Jersey
We’re tracking 3 recruiting chronic limb-threatening ischemia studies with a site in New Jersey, each written for real people, not researchers.
Recruiting studies in New Jersey
- NCT06311773Enrolling by invitation
Testing the Boomerang Catheter for severe leg artery disease
This trial tests a new device called the Boomerang Catheter for people with severe leg artery disease (CLTI) who have no other treatment options to save their limb. The goal is to see if this catheter can restore enough blood flow to help the leg heal.
Galloway, New JerseyAges 18 years+ - NCT05313165Recruiting
Stent procedure for poor blood flow in the leg ulcers and gangrene
This trial tests a new minimally invasive procedure (placing a small stent) to improve blood flow to a severely threatened foot or lower leg. It may help people whose ulcers or gangrene are not treatable with standard bypass or other surgeries.
Pomona, New JerseyAges 18–95 - NCT06330493Recruiting
Study of a drug-coated balloon for leg artery disease
This trial tests a special balloon coated with medication to open up blocked arteries below the knee in people with serious leg circulation problems. It aims to improve blood flow and avoid amputation.
Orange, New JerseyAges 18 years+
Where these studies are running in New Jersey
Institutions with a site for the recruiting chronic limb-threatening ischemia studies listed above.
- American Endovascular and Amputation Prevention
- American Endovascular and Amputation Prevention (AEAP)
- Holy Name Medical Center
- Vascular Institute at AMI
- Vascular Institute of Atlantic Medical Imaging
What taking part in a chronic limb-threatening ischemia study involves
A screening visit first
Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.
Care at a nearby site
Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.
You stay in control
Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.
The team decides eligibility
Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.
Chronic Limb-Threatening Ischemia trials in other states
Common questions
- Are there chronic limb-threatening ischemia clinical trials in New Jersey?
- Yes. We're currently tracking 3 recruiting chronic limb-threatening ischemia studies with a site in New Jersey, each rewritten in plain language so you can see what it's testing and who it's for.
- How do I find out if I qualify for a chronic limb-threatening ischemia study in New Jersey?
- Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Do I have to live in New Jersey to take part?
- Not necessarily. These studies have a site in New Jersey, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
- Does it cost anything to join a chronic limb-threatening ischemia trial?
- Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.
Not the right time?
New chronic limb-threatening ischemia studies open in New Jersey regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.